Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mizuki Kurozumi"'
Publikováno v:
Journal of atherosclerosis and thrombosis.
The Achilles tendon (AT) thickening may be affected by several factors (e.g., lipid disorders or age). This study aims to determine the prevalence rate of AT thickening in patients with coronary artery disease (CAD) and investigate the correlation be
Autor:
Ichiro Matsumoto, Shusei Hayashino, Mizuki Kurozumi, Jun Kunikata, Tetsuo Minamino, Tsunetatsu Namba, Yuichiro Takagi, Shinjiro Miyazaki
Publikováno v:
Geriatrics & Gerontology International. 21:411-415
AIM Skeletal muscle mass is associated with exercise tolerance in patients with chronic heart failure (CHF). Anthropometric indicators are used to evaluate skeletal muscle mass, as these can be easily assessed in clinical practice. However, the assoc
Publikováno v:
Journal of cardiology. 80(2)
Clinical studies have shown that the ratio of eicosapentaenoic acid to arachidonic acid (EPA/AA ratio) as well as the triglyceride (TG) levels can be considered as independent risk factors for cardiovascular diseases. The aim of this study was to inv
Publikováno v:
Journal of cardiology. 78(6)
Background The role of serum uric acid (SUA) as an independent risk factor for coronary artery disease remains unclear. The aim of this study was to investigate whether the SUA levels could affect the incidence of major adverse cardiac events (MACE)
Autor:
Yuichi Miyake, Ichiro Matsumoto, Motoi Shiomi, Naoki Nishimoto, Mizuki Kurozumi, Takahisa Noma, Kaori Ishikawa, Kazushi Murakami, Tetsuo Minamino, Ryo Kawakami, Yuichiro Takagi, Makoto Ishizawa
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 81(10)
BACKGROUND The lipid component of coronary plaques is associated with their vulnerability. The aim of this study was to investigate which coronary risk factors were relevant in predicting serial changes in the lipid component of coronary plaques as e
Publikováno v:
Journal of cardiology. 71(1)
Some studies have demonstrated that low-density lipoprotein cholesterol (LDL-C) lowering therapy is one of the most important strategies to prevent coronary artery disease. Also, serum triglycerides (TG) and high-density lipoprotein cholesterol (HDL-